Finistere Ventures

Finistere Ventures, established in 2005, is a global venture capital firm headquartered in San Diego, California, with additional offices in Menlo Park, Dublin, and Tel Aviv. The firm specializes in investing in early to growth-stage companies across life sciences, information technology, sustainability, and agricultural technology sectors. Its focus includes medical devices, diagnostics, and food, energy, and health-related technologies. Finistere invests between $0.35 million to $4.5 million, typically holding investments for five years. The firm operates globally, with a presence in the United States, Israel, Australia, New Zealand, and Latin America.

Kirk Belsby

Managing Director

Steven Goldberg Ph.D

Partner

Steve Goldberg

Partner

Spencer Maughan

Co-Founder and Managing Partner

Donal Ryan

Venture Partner

Dean Tilyard

Venture Partner

Past deals in Pets

Animol Discovery

Series B in 2023
Animol specializes in developing proprietary veterinary small molecule drugs using its innovative technology platform. Led by industry experts, the company focuses on creating breakthrough medicines tailored to the specific needs of animal patients.

Animol Discovery

Series B in 2022
Animol specializes in developing proprietary veterinary small molecule drugs using its innovative technology platform. Led by industry experts, the company focuses on creating breakthrough medicines tailored to the specific needs of animal patients.

POP

POP offers a nutrient-packed supplement for pet dogs to reduce inflammation and support whole-body health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.